Profil
Luigi Colombo is the founder of Biosearch Italia SpA, which was founded in 1996.
He is currently the Chief Executive Officer at SilverAid SRL, the Director at Nocturnal Labs SpA, and the Chief Operating Officer at EPOK Therapeutics, Inc. (starting in 2023).
Mr. Colombo previously worked as the Executive Director at Ulisse BioMed SpA. He obtained his undergraduate degree from the University of Milan.
Aktive Positionen von Luigi Colombo
| Unternehmen | Position | Beginn |
|---|---|---|
SilverAid SRL
SilverAid SRL Medical SpecialtiesHealth Technology Designs, develops, produces and distributes dental equipment | Vorstandsvorsitzender | - |
EPOK Therapeutics, Inc.
EPOK Therapeutics, Inc. BiotechnologyHealth Technology Develops biologics to treat metabolic diseases | Geschäftsführer | 01.02.2023 |
Nocturnal Labs SpA | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Luigi Colombo
| Unternehmen | Position | Ende |
|---|---|---|
| HELYX INDUSTRIES S.P.A. | Direktor/Vorstandsmitglied | - |
Biosearch Italia SpA
Biosearch Italia SpA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Gründer | - |
Ausbildung von Luigi Colombo
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Biosearch Italia SpA
Biosearch Italia SpA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Milan
University of Milan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ulisse BioMed SpA
Ulisse BioMed SpA Medical SpecialtiesHealth Technology Develops and manufactures diagnostic platforms and products | Health Technology |
SilverAid SRL
SilverAid SRL Medical SpecialtiesHealth Technology Designs, develops, produces and distributes dental equipment | Health Technology |
EPOK Therapeutics, Inc.
EPOK Therapeutics, Inc. BiotechnologyHealth Technology Develops biologics to treat metabolic diseases | Health Technology |
Nocturnal Labs SpA |
















